Lung function testing in patients with pulmonary arterial hypertension

被引:0
作者
Escribano, PM
Sánchez, MAG
de Atauri, MJD
Frade, JP
García, IM
机构
[1] Univ Madrid, Hosp 12 Octubre, Serv Neumol, Madrid 28041, Spain
[2] Univ Madrid, Hosp 12 Octubre, Serv Cardiol, Madrid 28041, Spain
[3] Univ Madrid, Hosp 12 Octubre, Unidad Epidemiol Clin, Madrid 28041, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2005年 / 41卷 / 07期
关键词
lung function tests; pulmonary hypertension : physiopathology; diagnosis;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVE: The main objective was to describe the results of lung function testing in a series of 120 patients with pulmonary arterial hypertension, and the secondary objective was to compare these findings with hemodynamic variables. PATIENTS AND METHODS: This was a descriptive study of lung function in 120 patients with stable pulmonary arterial hypertension (Evian/Venice groups 1 and 4) studied until January 2002 in the Pulmonary Hypertension and Lung Transplant Working Group attached to the Cardiology Department of the Hospital Universtario 12 de Octubre in Madrid, Spain. Data were collected retrospectively for the first 47 patients (1981 to 1995) and prospectively thereafter for the remaining 73 patients. The diagnosis was idiopathic arterial hypertension or hypertension associated with collagenosis, chronic pulmonary embolism, cardiac shunt, or toxic oil syndrome (30 cases). RESULTS: In the group as a whole, forced vital capacity, forced expiratory volume in 1 second, and total lung capacity were normal; mean (SD) values revealed low carbon dioxide diffusing capacity (67.6% [23.2%]), and moderate hypoxemia (65.8 [15.4] mm Hg). No significant associations were observed between lung function and hemodynamic parameters. Mean age in the toxic oil syndrome group was lower (33.7 [11.4] years), and these patients had higher mean scores on the New York Heart Association scale (3.3 [0.5]) and for pulmonary vascular resistance (20.3 [8.1] kPa center dot L-1 center dot s). CONCLUSIONS: Lung function was studied in a series of 120 patients with pulmonary arterial hypertension (Evian/Venice groups 1 and 4), 30 of whom had toxic oil syndrome. No significant associations were found between lung function and hemodynamic parameters.
引用
收藏
页码:380 / 384
页数:5
相关论文
共 50 条
[41]   Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension [J].
Zelt, Jason G. E. ;
Hossain, Alomgir ;
Sun, Louise Y. ;
Mehta, Sanjay ;
Chandy, George ;
Davies, Ross A. ;
Contreras-Dominguez, Vladimir ;
Dunne, Rosemary ;
Doyle-Cox, Caroyln ;
Wells, George ;
Stewart, Duncan J. ;
Mielniczuk, Lisa M. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (07) :675-685
[42]   Utility of Echocardiography Versus BNP Level for the Prediction of Pulmonary Arterial Pressure in Patients With Pulmonary Arterial Hypertension [J].
Goto, Kosaku ;
Arai, Masashi ;
Watanabe, Atai ;
Hasegawa, Akira ;
Nakano, Akihiko ;
Kurabayashi, Masahiko .
INTERNATIONAL HEART JOURNAL, 2010, 51 (05) :343-347
[43]   Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts [J].
Vijarnsorn, Chodchanok ;
Durongpisitkul, Kritvikrom ;
Chungsomprasong, Paweena ;
Bositthipichet, Densiri ;
Ketsara, Salisa ;
Titaram, Yuttapon ;
Chanthong, Prakul ;
Kanjanauthai, Supaluck ;
Soongswang, Jarupim .
PLOS ONE, 2018, 13 (04)
[44]   How to select the appropriate candidate of pulmonary arterial hypertension: specific therapy in elderly patients with pulmonary hypertension [J].
Yaylali, Yalin Tolga .
JOURNAL OF GERIATRIC CARDIOLOGY, 2017, 14 (01) :17-19
[45]   Safety of regadenoson stress testing in patients with pulmonary hypertension [J].
Moles, Victor M. ;
Cascino, Thomas ;
Saleh, Ashraf ;
Mikhova, Krasimira ;
Lazarus, John J. ;
Ghannam, Michael ;
Yun, Hong J. ;
Konerman, Matthew ;
Weinberg, Richard L. ;
Ficaro, Edward P. ;
Corbett, James R. ;
McLaughlin, Vallerie V. ;
Murthy, Venkatesh L. .
JOURNAL OF NUCLEAR CARDIOLOGY, 2018, 25 (03) :820-827
[46]   Lung or Heart-Lung Transplant in Pulmonary Arterial Hypertension: What Is the Impact of Systemic Sclerosis? [J].
Gadre, Shruti K. ;
Minai, Omar A. ;
Wang, Xiao-Feng ;
Zhang, Qi ;
Budev, Marie ;
Tonelli, Adriano R. .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 (06) :676-684
[47]   Incidence and Significance of Pericardial Effusion in Patients With Pulmonary Arterial Hypertension [J].
Shimony, Avi ;
Fox, Benjamin D. ;
Langleben, David ;
Rudski, Lawrence G. .
CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (06) :678-682
[48]   Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension [J].
Xanthouli, Panagiota ;
Theobald, Vivienne ;
Benjamin, Nicola ;
Marra, Alberto M. ;
D'Agostino, Anna ;
Egenlauf, Benjamin ;
Shaukat, Memoona ;
Ding, Cao ;
Cittadini, Antonio ;
Bossone, Eduardo ;
Koegler, Maria ;
Gruenig, Ekkehard ;
Muckenthaler, Martina U. ;
Eichstaedt, Christina A. .
RESPIRATORY RESEARCH, 2021, 22 (01)
[49]   Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography [J].
Mercurio, Valentina ;
Hassan, Hussein J. ;
Naranjo, Mario ;
Cuomo, Alessandra ;
Mazurek, Jeremy A. ;
Forfia, Paul R. ;
Balasubramanian, Aparna ;
Simpson, Catherine E. ;
Damico, Rachel L. ;
Kolb, Todd M. ;
Mathai, Stephen C. ;
Hsu, Steven ;
Mukherjee, Monica ;
Hassoun, Paul M. .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
[50]   Identifying early pulmonary arterial hypertension in patients with systemic sclerosis [J].
Condliffe, Robin ;
Kovacs, Gabor .
EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (04)